Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated:  12/31/1969
1315
mi
from 91732
Tyler, TX
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1315
mi
from 91732
Tyler, TX
Click here to add this to my saved trials
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2467
mi
from 91732
Burlington, VT
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2467
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated:  12/31/1969
1721
mi
from 91732
West Allis, WI
Clinical Performance Comparison of Two Contact Lenses
Clinical Evaluation of Two Silicone Hydrogel Frequent Replacement Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1721
mi
from 91732
West Allis, WI
Click here to add this to my saved trials
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status: Enrolling
Updated:  12/31/1969
2569
mi
from 91732
Waltham, MA
Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status: Enrolling
Updated: 12/31/1969
Ocular Immunology and Uveitis Foundation
2569
mi
from 91732
Waltham, MA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
105
mi
from 91732
Bakersfield, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
105
mi
from 91732
Bakersfield, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
323
mi
from 91732
Mountain View, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Northern California Retina Vitreous Associates
323
mi
from 91732
Mountain View, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
73
mi
from 91732
Oceanside, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
San Diego Retina Associates
73
mi
from 91732
Oceanside, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
366
mi
from 91732
Sacramento, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants Medical Group, Inc.
366
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
98
mi
from 91732
Santa Barbara, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants
98
mi
from 91732
Santa Barbara, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
149
mi
from 91732
Santa Maria, CA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
California Retina Consultants - Santa Maria
149
mi
from 91732
Santa Maria, CA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
804
mi
from 91732
Colorado Springs, CO
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Consultants of Southern Colorado PC; Clinical Research Department
804
mi
from 91732
Colorado Springs, CO
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
2238
mi
from 91732
Melbourne, FL
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Florida Eye Associates
2238
mi
from 91732
Melbourne, FL
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
1810
mi
from 91732
Pensacola, FL
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Retina Specialty Institute
1810
mi
from 91732
Pensacola, FL
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
1415
mi
from 91732
West Des Moines, IA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
1415
mi
from 91732
West Des Moines, IA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
1556
mi
from 91732
Chesterfield, MO
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
The Retina Institute - Chesterfield
1556
mi
from 91732
Chesterfield, MO
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
1573
mi
from 91732
Saint Louis, MO
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
The Retina Institute
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
385
mi
from 91732
Reno, NV
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Sierra Eye Associates
385
mi
from 91732
Reno, NV
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
1880
mi
from 91732
Cincinnati, OH
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Cincinnati Eye Institute
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
1762
mi
from 91732
Nashville, TN
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Tennessee Retina, P.C.
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
1907
mi
from 91732
Marietta, GA
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Georgia Retina, P.C.
1907
mi
from 91732
Marietta, GA
Click here to add this to my saved trials
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated:  12/31/1969
2002
mi
from 91732
Asheville, NC
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Status: Enrolling
Updated: 12/31/1969
Western Carolina Retinal Associate PA
2002
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
Comparison of Three Soft Bifocal Contact Lenses
Status: Enrolling
Updated:  12/31/1969
2134
mi
from 91732
Roanoke, VA
Comparison of Three Soft Bifocal Contact Lenses
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2134
mi
from 91732
Roanoke, VA
Click here to add this to my saved trials
1464
mi
from 91732
North Little Rock, AR
Clinical Research Facility
1464
mi
from 91732
North Little Rock, AR
Click here to add this to my saved trials
1355
mi
from 91732
Blue Springs, MO
1355
mi
from 91732
Blue Springs, MO
Click here to add this to my saved trials
1429
mi
from 91732
Lake Ozark, MO
1429
mi
from 91732
Lake Ozark, MO
Click here to add this to my saved trials
2074
mi
from 91732
Warren, OH
Clinical Research Facility
2074
mi
from 91732
Warren, OH
Click here to add this to my saved trials
2144
mi
from 91732
Kittanning, PA
Clinical Research Facility
2144
mi
from 91732
Kittanning, PA
Click here to add this to my saved trials
2560
mi
from 91732
Warwick, RI
Clinical Research Facility
2560
mi
from 91732
Warwick, RI
Click here to add this to my saved trials
1204
mi
from 91732
Chamberlain, SD
1204
mi
from 91732
Chamberlain, SD
Click here to add this to my saved trials
2467
mi
from 91732
Burlington, VT
Clinical Research Facility
2467
mi
from 91732
Burlington, VT
Click here to add this to my saved trials
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated:  12/31/1969
570
mi
from 91732
Salt Lake City, UT
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated:  12/31/1969
2350
mi
from 91732
Virginia Beach, VA
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2350
mi
from 91732
Virginia Beach, VA
Click here to add this to my saved trials
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated:  12/31/1969
841
mi
from 91732
Laramie, WY
Vistakon Investigational Lens Worn as a Single Use Daily Wear
Status: Enrolling
Updated: 12/31/1969
841
mi
from 91732
Laramie, WY
Click here to add this to my saved trials
12
mi
from 91732
Brea, CA
12
mi
from 91732
Brea, CA
Click here to add this to my saved trials
34
mi
from 91732
Canoga Park, CA
Clinical Research Facility
34
mi
from 91732
Canoga Park, CA
Click here to add this to my saved trials
28
mi
from 91732
Corona, CA
Clinical Research Facility
28
mi
from 91732
Corona, CA
Click here to add this to my saved trials
2473
mi
from 91732
Bridgeport, CT
Clinical Research Facility
2473
mi
from 91732
Bridgeport, CT
Click here to add this to my saved trials
2127
mi
from 91732
Jacksonville, FL
Clinical Research Facility
2127
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
2136
mi
from 91732
Tampa, FL
Clinical Research Facility
2136
mi
from 91732
Tampa, FL
Click here to add this to my saved trials
2184
mi
from 91732
Winter Park, FL
Clinical Research Facility
2184
mi
from 91732
Winter Park, FL
Click here to add this to my saved trials
1919
mi
from 91732
Roswell, GA
Clinical Research Facility
1919
mi
from 91732
Roswell, GA
Click here to add this to my saved trials
1802
mi
from 91732
Mishawaka, IN
Clinical Research Facility
1802
mi
from 91732
Mishawaka, IN
Click here to add this to my saved trials
2578
mi
from 91732
Boston, MA
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
1355
mi
from 91732
Blue Springs, MO
1355
mi
from 91732
Blue Springs, MO
Click here to add this to my saved trials
1350
mi
from 91732
Independence, MO
Clinical Research Facility
1350
mi
from 91732
Independence, MO
Click here to add this to my saved trials
1429
mi
from 91732
Lake Ozark, MO
1429
mi
from 91732
Lake Ozark, MO
Click here to add this to my saved trials
2435
mi
from 91732
New York, NY
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
2214
mi
from 91732
Raleigh, NC
Clinical Research Facility
2214
mi
from 91732
Raleigh, NC
Click here to add this to my saved trials
2047
mi
from 91732
Chagrin Falls, OH
Clinical Research Facility
2047
mi
from 91732
Chagrin Falls, OH
Click here to add this to my saved trials
2020
mi
from 91732
North Olmsted, OH
2020
mi
from 91732
North Olmsted, OH
Click here to add this to my saved trials